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Abstract
Ribozymes, or catalytic RNAs, were discovered a little more than 15 years ago. They are found in the organelles of plants
and lower eukaryotes, in amphibians, in prokaryotes, in bacteriophages, and in viroids and satellite viruses that infect plants.
An example is also known of a ribozyme in hepatitis delta virus, a serious human pathogen. Additional ribozymes are bound to
be found in the future, and it is tempting to regard the RNA component(s) of various ribonucleoprotein complexes as the
catalytic engine, while the proteins serve as mere scaffolding ^ an unheard-of notion 15 years ago! In nature, ribozymes are
involved in the processing of RNA precursors. However, all the characterized ribozymes have been converted, with some clever
engineering, into RNA enzymes that can cleave or modify targeted RNAs (or even DNAs) without becoming altered
themselves. While their success in vitro is unquestioned, ribozymes are increasingly used in vivo as valuable tools for studying
and regulating gene expression. This review is intended as a brief introduction to the characteristics of the different identified
ribozymes and their properties. ß 1999 Federation of European Microbiological Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Ribozymes, or catalytic RNAs, were ¢rst discov-
ered in the laboratory of Tom Cech, at the Univer-
sity of Colorado, in 1982. His research team found
that the ribosomal RNA precursor from Tetrahyme-
na thermophila contained an intron, a nonencoding
sequence that interrupts the gene, that was capable
of excising itself, in vitro, without any protein or
external energy source [1]. Shortly thereafter, Sid
Altman’s group, at Yale University, showed that
the RNA component of RNase P, M1 RNA, from
Escherichia coli was likewise able to process tRNA
precursors without any protein factors [2]. Cech and
Altman shared the Nobel Prize in Chemistry in 1989
for this work.
This seminal work ushered in a major research
activity, and RNA catalysis was soon found to be
widespread in nature, occurring in plants, bacteria,
viruses, and lower eukaryotes. Although ribozymes
are rare in vertebrates, one is found in humans. Sev-
en distinct catalytic RNAs are identi¢ed in nature.
This number is probably not exhaustive, and addi-
tional catalytic RNAs are bound to be found. It
appears that the RNA components of some, perhaps
many, ribonucleoprotein complexes may have cata-
lytic activity; for example, highly deproteinized ribo-
somes can still catalyze a peptidyl transfer reaction
[3,4], and nuclear mRNA splicing may be RNA-driv-
en (see below). Moreover, new ribozymes are being
generated, de novo, in the laboratory through com-
binatorial screening of randomized RNA sequences.
The fact that RNA can function as both a reser-
voir of genetic information and a catalyst of biolog-
ical reactions has inevitably raised the supposition
that RNA was the primordial biological molecule,
and there is much written both for and against this
idea ^ often based on the same experimental obser-
vations! The in vitro selection of catalytic RNAs, as
well as the demonstration that ribozymes can cata-
lyze polymerization reactions, has provided evidence
for this ([5] and references therein). The di⁄culty of
synthesizing discrete nucleotide building blocks
under what is considered to be prebiotic conditions,
much less the di⁄culty of forming speci¢c polymers
from them, provides evidence against it (e.g., [6]). In
the absence of a time machine, such speculations are
bound to be rich sources of discussion for some time
to come.
This article is intended as an overview of ribo-
zymes, their structures, and their properties. How-
ever, a thorough discussion could easily ¢ll a book;
therefore, I will limit my presentation to more gen-
eral properties of the molecules. Extensive reference
will be made to recent reviews, and I will generally
avoid citing articles that can be found through other,
more recent, sources. As this review is intended to
emphasize the structural features, as well as the bio-
logical functions, of ribozymes, I will not make ex-
tensive reference to the therapeutic or prophylactic
aspects nor will I discuss strategies for delivering and
expressing ribozymes in vivo. The reader is referred
to some extensive reviews [7^9]. An excellent review
of arti¢cial ribozymes can also be found elsewhere
[5].
2. General characteristics
Catalytic RNAs are broadly separated into two
classes based on their size and reaction mechanisms
(reviewed by [10^14]). The large catalytic RNAs con-
sist of RNase P, and the group I and group II in-
trons. These molecules range in size from a few hun-
dred nucleotides to around 3000. They catalyze
reactions that generate reaction intermediates and
products with 3P hydroxyls and 5P phosphates (Fig.
1a). The small catalytic RNAs include the hammer-
head, the hairpin (or paperclip), hepatitis delta and
VS RNA. These molecules range in size from V35
toV155 nucleotides. They use the 2P hydroxyl of the
ribose sugar as a nucleophile, and they generate
products with a 2P,3P-cyclic phosphate and a 5P hy-
droxyl (Fig. 1b). The relationship between the size
and the reaction mechanism of these molecules has
raised intriguing questions about their origins and
evolution. It may be that the reaction mechanism
and the size of the large ribozymes are needed to
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bring often very distal elements of the substrate into
close proximity. The small, self-cleaving, RNAs are
not faced with this constraint and perhaps this per-
mitted them to evolve smaller catalytic centers. It
remains possible, however, that the relationship be-
tween the size and reaction mechanism is simply for-
tuitous.
With one exception, all these RNAs catalyze reac-
tions that modify themselves. Hence, they cannot be
considered true enzymes or catalysts. The exception
is RNase P, which processes the 5P end of tRNA
precursors. It is the only known example of a natu-
rally occurring RNA-based enzyme. However, all
these molecules can be converted, with some clever
engineering, into true RNA enzymes that modify
other RNAs in trans without becoming altered them-
selves.
Ribozymes increase reaction rates by up to 1011-
fold and have reaction e⁄ciencies, kcat/Km, up to 108
M31 min31, which is in the range for di¡usion-con-
trolled duplex formation between oligonucleotides
[10]. While impressive, the rate enhancements pro-
vided by ribozymes are still V103-fold less than
those provided by protein enzymes catalyzing com-
parable reactions [15]. Moreover, ribozymes cannot
compare with proteins as multiple-turnover enzymes,
mostly because product release is so slow that the
catalytic site of the ribozyme is easily saturated.
This may be an inherent limitation of RNA enzymes,
but it could also re£ect evolutionary constraints,
since ribozymes generally catalyze intramolecular,
single-turnover, reactions in nature. An exhaustive
comparison of the enzymatic mechanistics of protein
and RNA enzymes has recently been made [15].
All known ribozymes have an absolute require-
ment for a divalent cation, which is generally
Mg2. Some, notably within the large catalytic
RNAs, require divalent cations for proper assembly
of the tertiary structures as well. On this basis, cata-
lytic RNAs are considered to be metalloenzymes,
and a general two-metal-ion reaction mechanism
has been proposed for the large catalytic RNAs,
based on analogy with the properties of protein met-
alloenzymes [16]. The role of divalent cations for the
small catalytic RNAs is less clear, but they are gen-
erally considered to be essential for catalysis (see [17]
for alternative view).
3. General properties of introns
Introns, or intervening sequences (IVS), are non-
encoding sequences that interrupt the coding, exon,
Fig. 1. Reactions catalyzed by RNAs. a: The reaction mecha-
nism of the large catalytic RNAs. The nucleophile BOH is the 3P
hydroxyl of a guanosine cofactor in the ¢rst step of group I
splicing, the 2P hydroxyl of a nucleotide, generally A, within the
intron in the ¢rst step of group II splicing, and a water molecule
in the RNase P-catalyzed reaction. b: The reaction mechanism of
the small catalytic RNAs. The reaction is most likely initiated by
the activation of the 2P hydroxyl on the ribose located at the
scissile bond, and it results in a product with a 2P,3P-cyclic phos-
phate. The nature of the activation is still poorly understood,
but it most likely involves a coordinated metal hydroxide. Notice
in both (a) and (b) that the net number of bonds is conserved
throughout the reaction.
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sequences. These introns must be removed, at the
RNA level, in order for the gene to be expressed
functionally. There are ¢ve major categories of in-
trons and splicing mechanisms. These consist of nu-
clear tRNA introns (reviewed by [18]), archaeal in-
trons (reviewed by [19]), nuclear mRNA introns
(reviewed by [20]), and the group I and group II
introns (reviewed by [10,21]). Of these introns,
some members of the group I and group II are
clearly capable of catalyzing their own excision, in
vitro, in an RNA-catalyzed fashion. However, genet-
ic analyses have revealed protein factors that are
often essential for group I and group II splicing in
vivo [22]. The nuclear tRNA and archaeal introns
clearly require protein factors (endonuclease and li-
gase). Nuclear mRNA introns may represent an in-
termediate state. These introns are spliced within
large (40^60S) ribonucleoprotein particles (RNP),
which consist of a number of small nuclear RNAs
(snRNAs) and proteins [20]. However, it is increas-
ingly thought that it is the snRNAs that are the
chemical engines of the complex as well as the deter-
minants of the splice sites [23].
One of the oddities of group I and group II in-
trons, which makes the term ‘intron’ something of an
oxymoron, is that they sometimes encode proteins
that are required in vivo either for splicing activity
or for intron mobility (reviewed by [22]). The former
are intron maturases, which can be highly speci¢c for
the intron that encodes it. The latter are endonu-
cleases with reverse-transcriptase properties. These
proteins are involved in intron ‘homing’, where
crosses in yeast (the best studied genetically) result
in the transfer of the intron into the intronless allele
of the gene. There is also intron transposition (or
‘retrohoming’), where the intron is inserted into oth-
er alleles. The widespread, but scattered, distribution
of introns ^ especially introns with high sequence
similarity occupying the same location in di¡erent
organisms ^ suggests the possibility for horizontal
transfer of introns; thus these introns may act some-
what akin to infectious agents. In group I introns,
Fig. 2. The structure of group I introns. a: The ‘classical’ depiction of the secondary structure of the rRNA intron from T. thermophila,
showing the phylogenetically conserved sequences P, Q, R, and S (circled) and the conserved pairings P1^P9. Nonconserved elements are
designated by additional numbers or letters (e.g., P9.1 and P5c). The IGS sequence, which forms P1 and P10, is as indicated. The exon
sequences are indicated as heavy lines and the splice sites by the arrows. The insert shows the 5P end of the L-21 ribozyme, which is used
in various reactions in trans, with a bound substrate. b: The new secondary structure depiction that more accurately represents the rela-
tionships of the di¡erent structural elements. The heavy lines are exon sequences and the very light ones are used to bridge the di¡erent
elements, which are very close in tertiary space. c: A computer-generated model of the catalytic core of the Tetrahymena intron. The
exon sequences are shown in solid and the intron as outline. This ¢gure shows the intron after the ¢rst reaction, where the nonencoded
guanosine, G1, is attached to the 5P end of the intron and the 3P hydroxyl of the 5P exon is posed to make a nucleophilic attack at the
3P splice site. This ¢gure is reprinted with permission from [27].
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mobility is apparently catalyzed by proteins alone
and a functional (active) intron is not required. In
group II, the intron itself is essential for activity and
the intron RNA actually becomes inserted into the
double-stranded DNA substrate [24,25].
3.1. Group I introns
Group I introns range in size from a few hundred
nucleotides to around 3000. They are abundant in
fungal and plant mitochondria, but they are also
found in nuclear rRNA genes, chloroplast DNA
(ctDNA), bacteriophage, eukaryotic viruses, and in
the tRNA of ctDNA and eubacteria. In short, they
are widely found except in higher eukaryotes (i.e.,
vertebrates; reviewed by [10,21,26]). The various
group I introns have little sequence similarity, but
they are characterized by four short conserved se-
quence elements, called P, Q, R, and S (Fig. 2a). P
can always partially base-pair with Q, and R can
always partially base-pair with S. In addition, all
group I introns can fold into distinctive, phylogeneti-
cally conserved, secondary structures consisting of 10
paired segments (P1^P10; Fig. 2). Additional se-
quences, including large open reading frames
(ORF), and structures are often found, but they do
not disrupt the catalytic core, which consists of P3,
P4, P6 and P7. However, their presence is used to
subdivide the introns into various subgroups [27,28].
The secondary structure was originally deduced
from computer modeling based on phylogenetic
comparisons and, in the case of the Tetrahymena
intron, on limited structural probing [29^31]. Addi-
tional evidence for this structure comes from enzy-
matic and chemical probing studies, additional phy-
logenetic analyses and from physical approaches
(reviewed by [10,21,26,28]). These studies have con-
¢rmed the overall structure and revealed other im-
portant interactions, which have resulted in a new
secondary structure depiction that more accurately
re£ects the spatial relationship of the di¡erent ele-
ments (Fig. 2b) [32].
The exon sequences are oriented relative to the
catalytic core by base pairings with an intron se-
quence called the internal guide sequence (IGS),
which constitutes P1 and P10 in the structure [29].
An additional pairing, called P9.0, further aligns the
intron-3P exon splice site [33,34]. It was so named
because it occurs between P8 and P9 in the second-
ary structure, the latter being named before the
interaction was discovered. The 5P exon contains a
highly conserved uridine on its 3P end, which forms a
functionally important UcG base pair with the IGS,
and the intron contains a conserved guanosine on its
3P end. Finally, there is a speci¢c binding site for the
guanosine cofactor that initiates the reaction. This
site involves a conserved G-C base pair in P7 [35].
Michel and Westhof [27] have made a very clever,
computer-generated, three-dimensional model of the
catalytic core based on careful phylogenetic compar-
isons (Fig. 2c). This model brings all the relevant
elements into proximity, and it has provided a sound
basis for additional studies. A crystal structure was
solved to 2.8 Aî for a 160-nucleotide fragment of the
Tetrahymena intron, consisting of P4^P6 [36]. While
this structure contains less than half of the catalytic
core of the enzyme and it tells us little about the
reaction mechanism, it has revealed several exciting
features. These include a tetraloop, GNRA (N is any
Fig. 3. Splicing mechanisms of group I and group II introns. In
both cases, a series of trans-esteri¢cation reactions are used to
excise the intron and ligate the exons. The net number of bonds
remains the same throughout. The reaction is initiated by a gua-
nosine cofactor in group I introns and by an internal adenosine
in group II. The splicing reaction of nuclear pre-mRNAs follows
the same pathway as group II introns, but it occurs on a large
ribonucleoprotein complex. Details are described in the text.
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base and R is purine), docking with its receptor,
several adenosine platforms, which are derived
from adjacent adenosines forming a pseudo-base
pair within the helix, and a ribose zipper, which in-
volves a network of hydrogen bonds between the 2P-
OH groups of ribose and acceptor groups of bases
within the shallow groove of helices [36,37].
Recently, a 5.0-Aî crystal structure has been solved
for a 247-nucleotide-long fragment of the Tetrahyme-
na intron, consisting of helices P3^P9 [38]. This new
structure shows the previously characterized P4^P6
domain (helices P4, P5, and P6) largely unchanged
and the P3^P9 domain (helices P3, P7, P8 and P9)
wrapped around it. The close packing of the two
domains creates a shallow cleft into which the P1
helix, containing the 5P splice site, could ¢t. The
structure also creates a particularly tight binding
site in the P7 helix for the guanosine cofactor that
initiates the splicing reaction. Unfortunately, the res-
olution is too low to visualize details within the
structure, and the crystal structure is still missing
the P1^P2 domain containing the splice site, so little
can be determined about the reaction mechanism.
However, it is clear that the computer generated
model for the catalytic core [27,28] is largely consis-
tent with this crystal structure. A triumph for com-
puter modeling of RNA structures!
The splicing reaction of group I introns was ¢rst
worked out for Tetrahymena thermophila (reviewed
by [10,21,26]), and it will form the basis for my fur-
ther discussion. Nevertheless, all characterized group
I introns follow essentially the same pathway. The
Tetrahymena intron is excised from the precursor
rRNA by a two-step transesteri¢cation reaction
(Fig. 3). The reaction is initiated by the nucleophilic
attack of the 3P hydroxyl of a guanosine cofactor at
the 5P splice site. The exon-intron phosphodiester
bond is cleaved and the guanosine forms a 3P,5P-
phosphodiester bond at the 5P end of the intron.
The now free 3P hydroxyl of the 5P exon then makes
a nucleophilic attack at the 3P splice site to form the
ligated exons and release the intron with the non-
encoded guanosine.
Nucleotides close to the 5P end of the intron are
realigned on the IGS and the highly conserved 3P
terminal guanosine of the intron makes a nucleo-
philic attack at a phosphodiester bond between nu-
cleotides 15 and 16 or between nucleotides 19 and 20
within the intron in a reaction that is analogous to
the ¢rst step of splicing. The intron is circularized
(C-15 or C-19) and a small fragment containing the
nonencoded guanosine is released. The circular prod-
uct is also found in vivo, and its formation presum-
ably helps to drive the reaction to completion.
Although the circularization reaction is not univer-
sally conserved among group I introns, it is very
common. Each step is essentially the forward or re-
verse of the same reaction, and the total number of
phosphodiester bonds is conserved. Each step is fully
reversible, and no external energy source is needed.
The intron can fully reintegrate into rRNAs both in
vitro and in vivo ([39] and reference therein). The
phosphodiester bonds are inverted during the reac-
tion, which is consistent with an SN2, in-line, reac-
tion mechanism (see [10,26]).
The circular product is normally considered the
end product of the reaction, but the released intron
retains catalytic activity and substrate speci¢city. For
T. thermophila, a linear form of the intron lacking
the ¢rst 21 and the last ¢ve nucleotides (L-21 ScaI)
will catalyze a wide range of reactions on substrates
added in trans. These include sequence-speci¢c endo-
nuclease, nucleotidyltransferase, ligase and phospha-
tase activities ([10,21,26]). Substrate speci¢city is
changed by altering the IGS sequence. Because the
reactions are catalyzed using the 3P hydroxyl, they
will work on both RNA and DNA substrates,
although the latter has a much lower binding a⁄nity
and hence less activity. Since the L-21 ScaI RNA is
unaltered in the reaction, it is considered a true
RNA-based enzyme.
The properties of group I introns lend themselves
to a number of di¡erent applications. The L-21 ScaI
version of the Tetrahymena intron has been commer-
cially sold as an RNA restriction enzyme. Circularly
permutated precursor RNA, which contains end-to-
end fused exons inserted within the middle of the
intron sequence, is used to generate circular exon
molecules by an ‘inverse’ splicing reaction [40]. A
variant of this technique is used to generate circular,
trans-cleaving, HDV ribozymes in vitro [41] and in
vivo [42], which are more resistant to nucleases. A
trans-splicing reaction can repair a truncated lacZ
transcript in Escherichia coli [43] and in the cyto-
plasm of mammalian cells [44]. A trans-splicing in-
tron can also change mutant L-globin transcripts, in
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sickle cell anemia, into mRNAs coding for antisick-
ling Q-globin in human erythroid lineage cells [45].
3.2. Group II introns
Group II introns range in size from several hun-
dred to around 2500 nucleotides. Although they are
much less widely distributed than group I introns,
they are found in fungal and plant mitochondria,
in chloroplasts of plants, in algae, in eubacteria
and especially in the chloroplasts of the protist Eu-
glena gracilis (reviewed by [10,21,46,47]). Most are
present in mRNAs, but a few also occur in tRNA
and rRNA genes. In contrast to the extensively an-
alyzed group I introns, much less is known about
group II introns. This is partly because of their
more limited distribution but also because very few
of them are found to be self-splicing in vitro. Those
that are autocatalytic require reaction conditions
that are far from physiological (e.g., 100 mM MgCl2,
500 mM (NH4)2SO4 and 45‡C; [48]).
The secondary structure of group II introns was
originally deduced from phylogenetic comparisons
and computer modeling [30,49]. It is normally de-
picted as six helical domains (I^VI) radiating as
spokes from a central wheel (Fig. 4). On the basis
of the structural features, group II introns are di-
vided into two major subclasses, although some in-
trons ¢t into neither class. Some contain long ORFs.
Important structural features have been di⁄cult to
elucidate because of their poor reactivity in vitro and
the di⁄culty of working with organelle-speci¢c mol-
ecules. However, it appears that only domains I and
V are indispensable [50]. In addition, domain V con-
tains most of the relatively few phylogenetically con-
served nucleotides found in group II introns and it
might constitute the reaction center [46,47,51]. Do-
main VI contains the highly conserved adenosine
that is generally used to initiate the splicing reaction.
Except for domains I and V, the domains can be
modi¢ed or deleted and the intron will retain some
catalytic activity. Optional ORFs are frequently lo-
cated in the loop of domain IV.
Degenerated forms of group II introns are found
in plant chloroplasts and mitochondria that often
lack recognizable cognates of the various domains.
These are called group III introns (reviewed by [52]);
they may require factors in trans for activity or be
assembled from parts of group II introns. These de-
generate introns provide a feasible pathway between
group II and nuclear mRNA splicing, where more
and more of the role of the intron is supplanted by
trans-acting factors [23,47]. This possibility is made
more plausible by the observation that some group
II and group III introns occur within other group II
or group III introns (called twintrons; [52]) and that
others are discontinuous. Segments of these latter
introns are transcribed within two or even three sep-
arate molecules from distant regions of the genome
and the exons are assembled by a trans-splicing re-
action (reviewed by [53]).
The 5P exon is aligned by interactions between two
intron binding sequences (IBS1 and IBS2), located
near the 3P end of the 5P exon, and two exon binding
sequences (EBS1 and EBS2), which are located in
domain I of the intron (Fig. 4). The 5P splice site is
further de¢ned by O-OP interactions. These interac-
tions are important both before and after 5P cleav-
age. The 3P splice site has multiple determinants,
comprising N-NP, Q-QP, and other as yet unidenti¢ed
interactions. As yet, no tertiary model has been pro-
posed.
Fig. 4. The secondary structure of group II introns. This cartoon
is a generalization from a number of di¡erent introns. The exon
sequences are indicated as heavy lines and the splice sites by the
arrows. The characteristics of the central wheel with the radiating
domains is conserved, but the characteristics of the individual do-
mains vary considerably. Tertiary interactions are formed be-
tween IBS1-EBS1, IBS2-EBS2, K-KP, O-OP, N-NP and Q-QP ; the con-
nections between these elements are not shown for clarity. The
conserved adenosine used to initiate the splicing reaction is indi-
cated in domain VI. Additional tertiary interactions have been
identi¢ed, which vary with the intron (not shown).
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Unlike group I introns, where the ¢rst and second
steps are thought of as forward and reverse steps of
the same reaction, implying a single catalytic site,
group II introns use two di¡erent nucleophiles (2P
and 3P hydroxyls) and both steps show the same
stereospeci¢city ([46,47] and references therein).
This suggests that there are two independent reaction
centers or that there is a single site that switches
substrates [16].
The splicing reaction is generally initiated by the
nucleophilic attack of the 2P hydroxyl of a highly
conserved adenosine in domain VI to form a distinc-
tive structure, called a lariat, containing 3P-5P and 2P-
5P phosphodiester bonds at the adenosine branch site
(Fig. 3). The now free 3P hydroxyl of the 5P exon
then makes a nucleophilic attack at the 3P splice
site to form the ligated exons and release the intron,
still as a lariat. The reaction can also be initiated,
both in vitro and in vivo, by the nucleophilic attack
of water [48,54], although this is not a typical route.
In this case, the intron is released as a linear mole-
cule. As mentioned above, these reactions can also
be catalyzed in trans from separate transcripts. The
splicing mechanism and the lariat product are re-
miniscent of those found in nuclear mRNA splicing,
and it provides an additional evolutionary link be-
tween the two splicing reactions [23,47].
The applications of group II introns are more lim-
ited than those of group I. Nevertheless, it can cata-
lyze the cleavage of ligated precursors using the en-
ergy of a phosphoanhydride bond, ligate RNA to
DNA, and cleave single-stranded DNA substrates
[55]. It is also used to circularize exon sequences
[56], as described above for group I introns. How-
ever, the fact that the intron RNA becomes inserted
into double-stranded DNA during intron homing
[24,25] suggests that other applications will soon be
found.
4. RNase P
RNase P is a ubiquitous enzyme in all character-
ized organisms that processes the 5P termini of tRNA
precursors (reviewed by [10,57^60]). In eubacteria,
RNase P exists as a ribonucleoprotein complex, con-
sisting of a large RNA of about 350^400 nucleotides
(M1 RNA in E. coli) and a small basic protein of
V14 kDa (C5 in E. coli). The basic protein is essen-
tial for activity in vivo, however the RNase P RNA,
Fig. 5. Characteristics of RNase P RNA. a: The proposed secondary structure of M1 RNA, the RNA component of RNase P from E.
coli. b: The computer-modeled tertiary structure of (a). The black spheres represent invariant nucleotides at the catalytic site and con-
served nucleotides in the T-loop recognition site. Note that these conserved residues are clustered close to each other in what forms the
catalytic core of the molecule. This ¢gure is modi¢ed from [71]. c: Synthetic substrates for RNase P from prokaryotes and eukaryotes.
The EGS, which is used to de¢ne the target speci¢city, is shown bound to the substrate (boxed) and the cleavage site is indicated by an
arrow.
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by itself, can catalyze the reaction in vitro [2]. This
reaction requires high salt concentrations (e.g., 1 M
K or NH4 and 10 mM MgCl2 ; [60]), which sug-
gests that the basic protein component acts only as
an electrostatic shield to promote binding between
the RNA enzyme and the RNA substrate. However,
the protein also a¡ects cleavage-site speci¢city and
turnover, so its full role in the reaction is still unclear
(reviewed by [58,60]). RNase P from E. coli will also
process other substrates that partially resemble
tRNAs (e.g., 4.5S RNA [61]), but these reactions
appear to be relatively minor. RNase P RNA is
the only characterized ribozyme that, unmodi¢ed,
acts in trans on multiple substrates, and hence it is
considered the only true, naturally occurring, RNA
enzyme.
RNase P from the nuclei and mitochondria of eu-
karyotes also exist as ribonucleoprotein complexes,
although they generally have much higher protein
contents (ca. 50^70% versus ca. 10% for eubacteria
[57]). Moreover, while the RNA component is inevi-
tably found to be essential, the RNase P RNA from
eukaryotes has never been shown to have catalytic
activity. Archaebacteria have many properties that
make them more similar to the eukaryotes than to
the eubacteria, and they likewise are not known to
have RNA-alone catalytic activity [60].
There is evidence that another ribonuclease in eu-
karyotes, RNase MRP, is closely related, and per-
haps homologous (i.e., evolutionarily related), to
RNase P (reviewed by [62,63]). It is a ribonucleopro-
tein complex that participates in nucleolar pre-rRNA
processing. The RNA component can fold into sim-
ilar secondary structures as RNase P RNA and, in
yeast, it shares common protein components [64].
However, like the eukaryotic RNase P, the RNase
MRP RNA has not been shown to have catalytic
activity by itself.
Although there is little sequence conservation, all
the eubacterial RNase P RNAs can be folded into
similar, although not identical, secondary structures
on the basis of comparative sequence analyses
[60,65,66]. The E. coli M1 RNA consists of 18 paired
helices (P1^P18; Fig. 5a). The Bacillus subtilis M1
RNA analog is more diversi¢ed from E. coli than
many of the other eubacteria. It folds into a similar
structure, but P6, P13, P14, P16 and P17 are missing
and it contains extra helices P5.1, P10.1, P15.1, and
P19 (not shown). These two RNAs are the most
extensively studied, but through a careful compara-
tive analysis of the di¡erent eubacteria, it is possible
to derive a common core structure consisting of heli-
ces P1^P5, P7^P12 and P15 [60]. However, the activ-
ity of this ‘minimal’ structure has not yet been dem-
onstrated.
Native RNase P RNAs di¡er from the phyloge-
netic minimum by having extra stems and stem-loop
structures. While probably not needed for catalysis,
these structures nevertheless lower the ionic strength
requirements and enhance their thermal stability [60].
Such elements may be redundant in the sense that
any single one can be deleted or modi¢ed without
signi¢cantly altering the activity, but it is not possi-
ble to simultaneously delete or modify all of them.
The RNase P RNA from eukaryotes and archaebac-
teria have little sequence similarity to their eubacte-
rial counterparts, but they can often be folded into a
universally conserved core structure as well [67].
Missing RNA elements from the structures may be
supplanted by the protein component(s), but this has
not been characterized.
Three-dimensional models of the E. coli M1 RNA
have been made by Westhof and Altman [68] and by
Harris et al. [69], and both groups have recently
re¢ned these models [70,71] (Fig. 5b). Three-dimen-
sional models for the B. subtilis RNase P RNA are
also available [70,71]. These are computer-derived
models based on data obtained from phylogenetic
comparisons, mutational analyses, chemical probing
and from crosslinking studies. It is beyond the scope
of this review to discuss these models, especially in
light of their speculative nature, but generally the
models have a good ¢t to the experimental data.
Both groups’ models have similar overall structures
and both provide a pocket or cleft into which the
tRNA substrate will ¢t. However, many of the spe-
ci¢c interactions vary; thus these models are ex-
pected to undergo continual re¢nement as additional
experimental data become available.
RNase P uses water as a nucleophile to cleave the
phosphodiester bond (Fig. 1a). The exact mechanism
by which the tRNA precursor is bound is still un-
clear. The 3P half of the acceptor stem is thought to
function as an external guide sequence (EGS), but it
does not uniquely de¢ne the cleavage site. The pri-
mary sequence does not seem to be important nor
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does any single element uniquely de¢ne the cleavage
site. Instead, recognition could result from several
redundant factors, including the distance along the
coaxially stacked T stem-loop and acceptor stem, the
3P terminal CCA sequence, the EGS alignment, and
a conserved guanosine 3P to the cleavage site (re-
viewed by [58,59]). Thus, recognition is largely, if
not entirely, based on tertiary interactions with the
substrate.
From studies using small substrates, it is possible
to design synthetic EGSs that can target any RNAs
for cleavage by RNase P in vitro or in vivo (Fig. 5c;
reviewed by [72]). The basis for this is that the EGS
binds to the target RNA and makes it look like a
tRNA substrate. In eubacteria, the minimal require-
ment is that it forms a short stem with a free NCCA
(Fig. 5c). The target sequence can be virtually any-
thing. In eukaryotes, the EGS-substrate complex
must more closely resemble a tRNA (Fig. 5c). This
reaction works in vitro, in bacteria and in human
cells [72]. A variant of this technique is to add the
appropriate EGS (here called an internal guide se-
quence or IGS) to the 3P end of the RNase P RNA.
This increases the e⁄ciency of the reaction, and it is
used to inactivate thymidine kinase mRNA from
herpes simplex virus in cell lines [73]. Yet, while
the therapeutic potential of RNase P has been dem-
onstrated, it has not been widely used in therapeutic
applications.
5. General properties of small catalytic RNAs
Self-cleaving RNAs are generally found in small
(V220 to V460 nucleotides long) RNA pathogens
of plants known as viroids, virusoids and linear sat-
ellite viruses (reviewed by [13,74]). However, they are
also found within satellite RNAs of salamanders,
Neurospora, and within another pathogenic satellite
virus found in man. The viroid and satellite RNAs
are generally replicated by an RNA-dependent roll-
ing-circle mechanism, and the catalytic domains are
thought to process the linear concatemers that are
generated into unit-length progeny.
The linear, unit-length progenies produced during
replication in vivo are subsequently ligated to form
closed-circular molecules that are used in the next
round of rolling-circle replication. It is reasonable
to expect that this is catalyzed by the ribozyme as
well since, mechanistically, it represents the reverse
of the cleavage reaction, and it would be analogous
to the splicing reaction carried out by the group I
and group II introns. However, in vitro only the
hairpin ribozyme shows signi¢cant ligation activity.
Protein factors may be involved in vivo or other, as
yet unidenti¢ed, RNA elements may be required.
Four motifs are characterized (described below),
and they all catalyze reactions that generate products
with 2P,3P-cyclic phosphates and 5P hydroxyls (re-
viewed by [13,74]; Fig. 1b). As with the previous
ribozymes, they all require a divalent metal ion, nor-
mally Mg2, for activity.
The intramolecular self-cleaving activity is con-
verted into a trans-cleaving activity by making the
‘substrate’ and ‘ribozyme’ into separate molecules.
However, the ‘substrate’ remains an integral part of
the structure of the active ribozyme, and hence the
ribozyme is often simply de¢ned as the unmodi¢ed
portion of the molecule and the substrate is the
cleaved portion. Hence, the ‘ribozyme’ may consist
of di¡erent sequence elements, depending on the
construct. The catalytic domains of these ribozymes
are small and relatively well characterized, and
they are more widely used in therapeutic applica-
tions. Each has characteristics that confer speci¢c
advantages and disadvantages as therapeutic agents.
The in vitro and ex vivo activity of cis-cleaving
forms of three of these self-cleaving ribozymes (ham-
merhead, hairpin and HDV) have been compared
[75].
5.1. Hammerhead ribozyme
The hammerhead ribozyme is probably the most
extensively studied of all the ribozymes, and it is the
motif most commonly found in the viroids and sat-
ellite RNAs (reviewed by [13]). Currently 16 ham-
merhead motifs are known in the plus and minus
strands of these plant pathogens. Three other ham-
merhead motifs are found in the satellite 2 RNAs
from the salamanders, Triturus vulgaris, Ambystoma
talpoideum and Amphiuma tridactylum ([13] and
references therein). This ribozyme was so named be-
cause its Australian discoverers found the secondary
structure, as originally drawn, to be reminiscent of
the head of a hammerhead shark. It is the smallest of
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the naturally occurring self-cleaving RNAs, at 40^50
nucleotides in length.
Analyses of the hammerhead ribozyme are volu-
minous (reviewed by [9,76^78]). It consists of three
helical regions, which are variable, and three single-
stranded regions that contain most of the highly con-
served nucleotides (Fig. 6a). The length of the helical
arms can be quite variable, and helix II can be re-
duced to two base pairs. Mutating any of the con-
served residues markedly reduces activity; conse-
quently, important functional groups are often
identi¢ed by incorporating synthetic nucleotide ana-
logs into the RNA (e.g., inosine for guanine; re-
viewed by [76]).
Cleavage occurs after an NUH triplet, where N is
any nucleotide, and H is any nucleotide except gua-
nosine. The most e¡ective triplet is GUC, but other
triplet combinations will work nearly as well ; their
relative activities have been compared, although the
ordering can vary depending on the method of anal-
ysis (reviewed by [8,9,77]). The reaction mechanism
is extensively studied, and it appears to involve a
metal-coordinated hydroxide, which probably di-
rectly activates the 2P hydroxyl ([9,76,78] and refer-
ence therein). The reaction products are consistent
with an SN2 (in-line) reaction mechanism; this was
suggested by an inversion of the phosphate at the
scissile linkage.
Fig. 6. Characteristics of the hammerhead ribozyme. a: The secondary structure of the hammerhead ribozyme showing the conserved se-
quence and structure. The dots represent nucleotides that can be anything, Y is a pyrimidine, R is a purine and H is any nucleotide ex-
cept guanosine. The arrow indicates the self-cleavage site. The boxed region shows the portion that is normally the substrate in trans-
cleaving versions of the ribozyme. The numbering is based on standardized nomenclature [104]. b: A new secondary structure drawing
that more accurately re£ects the spatial relationships of the di¡erent elements. This structure di¡ers from (a) in that it shows a loop in
stem III rather than in stem II. c: The solved crystal structure of the sequence shown in (b). This is an RNA-only structure infused with
Mg2, shown as spheres. Only the Mg2 ion close to the scissile bond is generally accepted as being functionally relevant (see text). This
¢gure is modi¢ed from [81].
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The hammerhead ribozyme was the ¢rst catalytic
RNA for which the complete X-ray crystal structure
was solved. There are now a number of such struc-
tures available with resolutions ranging from 2.6 Aî
to 3.1 Aî , as well as a structure derived from £uores-
cence resonance energy transfer (FRET; reviewed by
[76,78,79]). The molecule has a Y shape (Fig. 6b,c),
with stem I and stem II at the arms and stem III at
the base. Recently, the crystallized structure of a re-
action intermediate was determined using a tallo-5P-
C-methyl-ribose-modi¢ed ribozyme that is kinetically
blocked for the ¢nal cleavage reaction [80]. This lat-
ter structure is more compatible with an SN2 reac-
tion mechanism. This is in contrast to the previously
solved structures that showed the ribozyme in a
ground state that was incompatible with such a
mechanism. A second Mg2 binding site has poten-
tially been identi¢ed in another crystal structure that
could be involved in stabilizing the pentacoordinated
phosphate transition state [81]. However, the exist-
ence of this site is still debated (see [78]). Moreover,
there are other incompatibilities between the exper-
imental data and the crystalline structures [78], and
clearly additional work will be needed.
The hammerhead ribozyme is divided into sepa-
rate ‘ribozyme’ and ‘substrate’ in several ways, but
the one shown in Fig. 6a is the most commonly
used because most of the conserved residues are
contained within the ribozyme rather than in the
substrate. The hybridizing arms are varied to opti-
mize ribozyme activity and substrate speci¢city. Nor-
mally hybridizing arms of six or seven base pairs
are considered optimal, but for variable arms it is
better to have a long stem III and short stem I
than the reverse (reviewed by [9]). Often, a tetraloop
(frequently GAAA) is used for loop II and stem II
is GC-rich to further increase the stability of the
stem-loop. The malleability of the hammerhead
ribozyme makes it the most commonly used ribo-
zyme for in vivo studies, and there are many success-
ful examples (reviewed by [7^9]). A trans-cleaving
hammerhead ribozyme is approved for phase II clin-
ical trials against HIV-1 by Ribozyme Pharmaceut-
icals (RPI).
Fig. 7. Secondary structure of the hairpin ribozyme. a: The minus strand of sTRSV (numbering is that of the full-length virus). The ar-
row shows the cleavage site. b: The consensus sequence and structure, where dots are any nucleotide, Y is a pyrimidine and R is a pu-
rine. The boxed region represents the portion that is normally the substrate in trans-cleaving reactions. The substrate is numbered relative
to the cleavage site and the ‘ribozyme’ relative to the 5P end. This ¢gure is modi¢ed from [83] and it incorporates recent experimental
data from [105].
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5.2. Hairpin ribozyme
The hairpin ribozyme is found in three pathogenic,
plant, satellite viruses, although the one found in the
satellite virus associated with tobacco ring spot virus
(sTRSV) is the best characterized. It consists of four
stem regions that, when lined up coaxially, some-
what resemble a hairpin; interestingly, it was also
originally named ‘paperclip,’ which may, in fact, bet-
ter represent its overall three-dimensional shape (see
[13]; Fig. 7a). It consists of two noncontiguous se-
quences of 50 and 14 nucleotides within the minus
strand of sTRSV (reviewed by [13,17,82^84]. The
secondary structure was determined based on com-
puter-aided modeling, limited phylogenetic compari-
sons, mutational analyses and by in vitro selection.
The other hairpin ribozymes are found in the sat-
ellite viruses of arabis mosaic virus (sARMV) and
chicory yellow mottle virus (sCYMV), and they
mostly di¡er from the sequence shown in Fig. 7a
by nucleotide changes within the helical regions
that maintain the structure as shown. Indeed, the
mutational and in vitro selection analyses show
that the helical regions are structural elements that
can largely be changed, as long as the integrity of the
helices is maintained. Most of the conserved nucleo-
tides occur within the single-stranded regions. The
guanosine 3P to the cleavage site is essential, but
altering the other conserved positions can dramati-
cally reduce the activity as well. The bulged region
between helices III and IV contain a conserved mo-
tif, called a UV-loop motif, that is found in a diverse
group of RNAs, including viroids, 5S rRNA and the
sarcin-ricin loop of 28S rRNA [82]. However, the
role this motif plays in catalysis is still unknown.
The consensus sequence and structure are shown in
Fig. 7b.
Recently, a computer-generated tertiary model
was made that was based on preexisting structural
data and on the spatial distance of tolerated, inter-
domain, aryl-disul¢de crosslinks [85]. Additional in-
formation was also obtained by Walker et al. [86]
using FRET data. The current model shows helix I
coaxially stacked on helix II and helix IV coaxially
stacked on helix III. These two extended helices are
then bent so that helix II and helix III, and helix I
and helix IV are positioned side by side. This places
the two highly conserved bulged regions in proxim-
ity, and they could thus form the catalytic core.
However, this tertiary model is still preliminary
and additional data are required before the details
of the catalytic site are known.
A major advantage of the hairpin ribozyme lies in
its ability to catalyze both cleavage and ligation re-
actions e⁄ciently in vitro; this has greatly facilitated
in vitro selection experiments because new sub-
strates, with the appropriate PCR primer sites, are
easily generated ([82] and references therein). The
RNA-catalyzed ligation reaction is also thought to
be relevant in vivo, in that the RNA can both cleave
the linear multimers generated during rolling-circle
replication and ligate them to form the circular
RNA progeny. However, as with the other catalytic
motifs used in viroid replication, the cleavage-liga-
tion reaction must be carefully regulated in vivo to
prevent inappropriate cleavage, or ligation, of the
resulting progeny. The mechanism by which this is
accomplished is still unknown. Like the other cata-
lytic RNAs, the hairpin ribozyme reaction requires a
divalent cation. However, it appears that, unlike the
hammerhead ribozyme, the hydrated cation (usually
Mg2) is not directly coordinated to the phosphate;
moreover, the essential role of divalent cations has
recently been called into question (see [17]).
Since the ‘substrate’ portion of the cis-cleaving
hairpin ribozyme is discontinuous with the rest of
the molecule, it is obvious where to separate the
two domains (boxed region in Fig. 7b). The substrate
should contain the sequence RYN*GUC, where R is
a purine, Y is a pyrimidine and N is any nucleotide.
Cleavage occurs at the position indicated by a *.
Stem II should be four base pairs, but stem I can
be signi¢cantly extended (e.g., [87]), as can stem IV
[88]. Substrate speci¢city is changed by altering the
nonconserved residues within the base-paired region.
The hairpin ribozyme is used to target HIV-1 RNA
in cell culture, and it is currently approved for clin-
ical trials (see [84]). However, its e¡ective use as a
trans-cleaving ribozyme in vivo is still rather limited;
the reasons for this are unclear.
5.3. VS RNA ribozyme
The mitochondria of certain strains of Neurospora
contain the Varkud plasmid (a retroplasmid), which
encodes a reverse transcriptase, and a small, unre-
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lated, RNA (VS RNA). The VS RNA is transcribed
from circular or multimeric VS plasmid DNA by a
mitochondrial RNA polymerase, and the resulting
transcripts are subsequently site-speci¢cally cleaved
and ligated to form circular, 881 nucleotides long,
RNA monomers [89]. These monomers are then re-
verse transcribed and made double stranded to form
the mature VS plasmid.
In vitro transcribed VS RNA precursors are
cleaved and ligated by the RNA itself and this is
presumed to occur in vivo as well ([90] and referen-
ces therein). Of all the self-cleaving RNAs, the cata-
lytic properties of VS RNA are the most poorly
understood. At 154 nucleotides long it is also the
largest. The minimal sequence that retains catalytic
activity contains one nucleotide 5P and 153 nucleo-
tides 3P to the cleavage site. However, this struc-
ture can be reduced to 121^126 nucleotides by mak-
ing internal deletions within the helices [91]. An
RNA secondary structure is proposed, but except
for a tertiary interaction between loop I and loop
V, little is known about its overall conformation
(Fig. 8).
The catalytic domain of VS RNA is converted into
a trans-cleaving ribozyme by using a 144-nucleotide
fragment of the VS RNA from 640 to 881 (VS RNA
numbering; [92]). The minimal substrate consists of
one nucleotide 5P and 19 nucleotides 3P to the cleav-
age site, and it forms a short stem-loop structure. As
with RNase P, the ribozyme seems to recognize the
structure of the substrate largely as a helical domain.
The minimal sequence requirement 5P to the cleavage
site is a characteristic shared only with the HDV
ribozyme (see below) and it could make this ribo-
zyme suitable for 3P end trimming of RNAs ex-
pressed in vitro or in vivo. However, the uncertainty
in the substrate requirements and the lackadaisical
activity in trans have limited its application, although
recent experiments have improved its activity [93].
5.4. HDV ribozyme
The hepatitis delta virus (HDV) is a viroid-like
satellite virus of the hepatitis B virus (HBV), and it
is the sole example of such a virus in mammalian
systems (reviewed by [94,95]). It is widespread and
can cause severe fulminant hepatitis in infected pa-
tients. It is about 1700 nucleotides long, and it enc-
odes a single protein that is expressed in two forms
due to an RNA editing event. Both the genomic,
infectious strand, and the antigenomic strand have
self-cleaving domains (reviewed by [96^99]). Despite
previous pronouncements, no biologically relevant,
RNA-catalyzed, ligation reaction has been observed
in vitro, although the integrity of the RNA catalytic
domains is clearly essential for both the cleavage and
ligation reaction in vivo ([99] and references therein).
A possible mechanism for the biological control of
these reactions, to prevent inappropriate cleavage or
ligation, has been proposed [96].
The minimal domain containing self-cleaving ac-
tivity has one nucleotide 5P and 84 nucleotides 3P to
Fig. 8. Secondary structure of the VS RNA ribozyme. The arrow shows the cleavage site and numbering is that of the full-length VS
RNA. The trans-cleaving form consists of nucleotides 640^881 and the substrate is shown boxed.
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the cleavage site for both domains. Despite the se-
quence di¡erences, both sequences fold into similar
secondary structures, of which the pseudoknotted
structure shown in Fig. 9a is now the most widely
accepted. It consists of four stem regions; three of
these stems (I, II and IV) are largely structural ele-
ments, while the speci¢c sequences in hairpin III and
in the junctions I/IV and IV/II are more important.
The catalytic domains of HDV are known for their
ability to retain cis-cleaving activity at high temper-
atures and in the presence of denaturants (see [97]
and references therein). The tertiary structures have
been computer modeled for the genomic and antige-
nomic forms of the pseudoknot model ([100,101] ;
Fig. 9b) and for the antigenomic axehead variant
[102].
Recently, a 2.3-Aî crystal structure has been solved
for the genomic HDV ribozyme [103]. This was ac-
complished by replacing hairpin IV with a small
hairpin structure that binds tightly to the protein
U1A, a spliceosomal protein. By co-crystallizing
the RNA with the protein, the authors were better
able to obtain highly structured crystals that dif-
fracted to a high resolution. It also greatly facilitated
heavy metal substitution that is necessary for obtain-
ing crystal phasing. This structure is very similar to
the computer-predicted model, but it revealed some
unexpected results. There is an additional pseudo-
knot structure derived from base pairs between
C21 and C22, in loop III with G39 and G38, at
the base of helix I. These speci¢c interactions were
not previously predicted, although the importance of
the nucleotides were correctly derived [100] In addi-
tion, A43 and G74 stack on the end of helix IV to
form noncanonical base pairs and G10 forms an ex-
tension to helix II as previously predicted [97,98].
These interactions create a structure where helix IV
is rotated relative to the computer model and hairpin
III is more compressed. Nevertheless, the two struc-
tures are otherwise very similar. The crystal structure
provides an organized, almost protein-like, crevice
for the active site. Unfortunately, it reveals little
Fig. 9. Characteristics of the HDV ribozyme. a: The genomic and antigenomic ribozymes from HDV. Numbering of the nucleotides is
relative to the cleavage sites, indicated by arrows. Helical domains are separated by lines to facilitate the presentation. The length of stem
I is critical, although there is no evidence that the 31 base pair is needed. The typical trans-cleaving forms are separated in junction I/II,
where the substrates are shown boxed. The identities of the nonbase-paired residues in the substrate (boxed) are not important for trans-
cleaving activity. Additional base-pair interactions, that were recently derived for the genomic ribozyme, are shown as dashed lines. b:
Computer-generated three-dimensional model of the genomic catalytic domain. This ¢gure is modi¢ed from [100]. Recently, the crystal
structure for the genomic HDV ribozyme was obtained [103]. This structure is similar to that shown here except that there is an addition-
al pseudoknot interaction between C21 and C22 with G38 and G39. Moreover, G10 is stacked on helix II and A43 and G74 stack on
hairpin IV.
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about the reaction mechanism or the role of the
Mg2 ions.
As with the other ribozymes, the cis-cleaving ac-
tivity of the HDV ribozymes can be converted into a
trans-cleaving activity (reviewed by [97^99]). The
most common form is indicated in Fig. 9a. However,
other permutations are possible, including a large
substrate consisting of sequences 35 to V60 (num-
bering in Fig. 9a) and a small ribozyme consisting of
sequences from V60 to +84. Since most of the con-
served elements are contained within the substrate,
the practical utility of this latter form is somewhat
limited. A completely closed-circular variant of the
trans-cleaving ribozyme shown in Fig. 9a also has
been generated; a short loop was used to close the
end of stem II [41]. The absence of free ends makes
this ribozyme particularly resistant to the exonu-
cleases found in serum and the cellular environment.
It is possible to change the substrate binding se-
quence to target other RNAs. In theory, most sub-
strate sequences are possible, although a guanosine
at the 31 position, relative to the cleavage site, is
inhibitory and a purine-pyrimidine base pair at posi-
tion +1 is preferred. However, in practice many of
the changes in the substrate-binding sequence have
unpredictable e¡ects.
Up to now, the HDV ribozyme has a rather lim-
ited use in therapeutic applications, largely because
of the di⁄culty of obtaining high activity with the
trans-cleaving forms. However, because of the mini-
mal sequence requirements 5P to the cleavage site, the
cis-cleaving activity is useful for generating discrete
3P ends of RNA. This has applications, for example,
in processing ribozyme cassettes (transcripts contain-
ing multiple ribozyme units), for generating homoge-
neous ends on in vitro transcribed RNA or for the
expression of discrete viral RNA transcripts o¡ plas-
mid DNA ([99] and references therein).
6. Concluding comments
In this review I have attempted to summarize
brie£y the important features of the di¡erent cata-
lytic RNAs that have so far been identi¢ed. The
ribozyme ¢eld has advanced far in an incredibly
short time. There are seven ribozymes identi¢ed in
nature, and all of them have been engineered to
cleave or modify other RNAs in trans. Other ribo-
zymes have been created de novo, and they can cat-
alyze a variety of reactions. Moreover, other cellular
processes have signi¢cant RNA components (e.g.,
the spliceosome and ribosomes) where RNA cataly-
sis may play an important role. Additional ribo-
zymes are bound to be discovered in the future. Fi-
nally, the disappointment that many earlier
researchers had when working with ribozymes in
vivo has now opened up to new opportunities as
people have discovered new ways of dealing with
the intracellular environment. Ribozymes are now
an important component of future developments in
gene regulation. They are worth keeping an eye on.
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